Connect with others who understand.

sign up log in
About MyCOPDTeam

Daliresp is a prescription drug approved by the Food and Drug Administration (FDA) to reduce the risk of exacerbations in people with chronic obstructive pulmonary disease (COPD), chronic bronchitis, and a history of exacerbations. Daliresp is also referred to by its drug name, Roflumilast.

Daliresp is a phosphodiesterase inhibitor. Daliresp is believed to work by decreasing the amount of certain molecules that cause inflammation.

How do I take it?
Prescribing information states that Daliresp is generally taken once daily.

Daliresp comes in tablet form.

Side effects
The FDA-approved label for Daliresp lists common side effects including dizziness, decreased appetite, diarrhea, weight loss, nausea, back pain, flu-like symptoms, and trouble sleeping.

Rare but serious side effects listed for Dailyresp include suicidal thinking and weight loss.



Daliresp (Roflumilast) for COPD Questions

Continue with Facebook
Sign up with your email
Already a Member? Log in